Health ❯ Healthcare

Medications

Weight Loss Weight Loss Drugs GLP-1 Drugs Side Effects Weight Management GLP-1 GLP-1 Agonists Diabetes GLP-1 Receptor Agonists Weight Loss Medications

Study Finds Small Increased Hair‑Loss Risk with GLP‑1 Drugs

Regulators are reviewing hundreds of patient reports as researchers test whether rapid weight loss or nutrient shortfalls explain the association.

Study Finds GLP‑1 Drugs Cut Long‑Term Sick Leave by About 17%

New Studies and Policy Pilots Push GLP‑1 Drugs into Wider Use as Cost and Safety Questions Grow

Wegovy Pill Arrives in UK Private Market as Clinicians Flag Dosing and Safety Risks

Lizzo Says She’s Gained 20 Pounds and Reframes Her Wellness Story

GLP‑1 Use Reaches 11% of U.S. Adults as New Evidence Spurs Policy and Safety Scrutiny

Medicare Launches GLP‑1 Bridge to Offer Select Weight‑Loss Drugs for $50 a Month

Study Finds GLP‑1 Diabetes Drugs Linked to Fewer Deaths and Limb Procedures in People With PAD

Oxford Tool Predicts Individual Risk of Serious Statin-Related Muscle Disorders

Study Finds Small Rise in Smell and Taste Diagnoses Among People on GLP‑1 Diabetes Drugs

Anvisa Approves First Non‑Hormonal Drug for Menopausal Hot Flashes

Mexico Will Reclassify Tramadol as a Controlled Drug Starting July 14

NHS GP Advises Waiting 48–72 Hours Before Taking Ibuprofen After Sprains or Breaks

Amber Heat Warning Prompts Drug Safety Alerts for Millions

New Studies Find Less Movement and Behavioral Signals in GLP‑1 Weight‑loss Users

FDA Approves First Generic Single‑Dose Flu Drug

Brazilian-Made Semaglutide Pen Ozivy Now on Sale

MHRA Approves Wegovy Weight‑Loss Tablet as Private Demand Soars

New Data Show Lower Activity, Muscle Loss and Mood Changes Linked to GLP‑1 Weight Drugs

Meta-Analysis Finds Tirzepatide Produces Largest Average Weight Loss Among FDA‑Approved GLP‑1s